ABOGEN
LIVE

Serial Number

79337360

Owner

Suzhou Abogen Biosciences Co., Ltd.

Attorney

THOMAS HOXIE

Filing Date

Jan 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ABOGEN Trademark

Serial Number: 79337360 • Registration: 7862331

ABOGEN is a trademark filed by Suzhou Abogen Biosciences Co., Ltd. on January 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Suzhou Abogen Biosciences Co., Ltd. (3 trademarks)

Unit 501, Building B1,

Entity Type: 99

Trademark Details

Filing Date

January 18, 2022

Registration Date

July 15, 2025

Published for Opposition

November 22, 2022

Goods & Services

Pharmaceuticals for the treatment of viral diseases; human vaccine preparations; oral vaccine preparations; vaccines; immunostimulants; antivirals; pharmaceutical preparations for the treatment or prevention of cancer, and infectious diseases; bacteriological preparations for medical purposes; vaccines against pneumococcal infections; vaccine preparations; all of the foregoing for use in the treatment or prevention of cancer and infectious disease

Cancer research for medical purposes; scientific investigations for medical purposes, specifically for treatment or prevention of cancer and infectious diseases; product quality testing, specifically for products for the treatment or prevention of cancer and infectious diseases; medical research, specifically for treatment or prevention of cancer and infectious diseases; development of pharmaceutical preparations and pharmaceuticals, specifically for treatment or prevention of cancer and infectious diseases; medical research services, specifically research for the treatment or prevention of cancer and infectious diseases; pharmaceutical research services, specifically for research for the treatment or prevention of cancer and infectious diseases; medicines research services, specifically research for the treatment or prevention of cancer and infectious diseases; research and development services relating to medicines, specifically medicines for the treatment or prevention of cancer and infectious diseases; computer programming in the medical field, specifically relating to the treatment or prevention of cancer and infectious diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 5, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 5, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 15, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 15, 2025 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jun 24, 2025 TMBN
OPPOSITION TERMINATED NO. 999999
Jun 24, 2025 OP.T
OPPOSITION DISMISSED NO. 999999
Jun 24, 2025 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 13, 2023 OPNR
REFUSAL PROCESSED BY IB
Apr 19, 2023 RFNT
OPPOSITION INSTITUTED NO. 999999
Mar 27, 2023 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 22, 2023 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Mar 22, 2023 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 15, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2022 TROA
REFUSAL PROCESSED BY IB
Sep 21, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2022 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 16, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 7, 2022 REPR